Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Treading the boundary between cuteness and discomfort—innocence and harm—South Korean artist Jinjoo Jo’s illustrations express the tenuous relationship humans conjure with nature and a personal ...

Journavx works differently than other available medications, and its developer, the biotechnology juggernaut Vertex Pharmaceuticals, has positioned it as an important, non-opioid option for pain ...